These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 31625933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms.
    Pommergaard HC, Nielsen K, Sorbye H, Federspiel B, Tabaksblat EM, Vestermark LW, Janson ET, Hansen CP, Ladekarl M, Garresori H, Hjortland GO, Sundlöv A, Galleberg R, Knigge P, Kjaer A, Langer SW, Knigge U.
    J Neuroendocrinol; 2021 May; 33(5):e12967. PubMed ID: 33769624
    [Abstract] [Full Text] [Related]

  • 5. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M, Li Y, Li T, Zhang L, Zhou L.
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [Abstract] [Full Text] [Related]

  • 6. Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors.
    Watanabe A, Yip L, Hamilton TD, Loree JM, Stuart HC.
    Am J Surg; 2021 Jun; 221(6):1141-1149. PubMed ID: 33795127
    [Abstract] [Full Text] [Related]

  • 7. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
    Ezziddin S, Attassi M, Yong-Hing CJ, Ahmadzadehfar H, Willinek W, Grünwald F, Guhlke S, Biersack HJ, Sabet A.
    J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs).
    Scott AT, Breheny PJ, Keck KJ, Bellizzi AM, Dillon JS, O'Dorisio TM, Howe JR.
    Surgery; 2019 Jan; 165(1):166-175. PubMed ID: 30343949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
    Baptiste GG, Postlewait LM, Ethun CG, Le N, McInnis MR, Russell MC, Winer JH, Kooby DA, Staley CA, Maithel SK, Cardona K.
    J Surg Oncol; 2016 Aug; 114(2):163-9. PubMed ID: 27157897
    [Abstract] [Full Text] [Related]

  • 14. Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival.
    Keck KJ, Choi A, Maxwell JE, Li G, O'Dorisio TM, Breheny P, Bellizzi AM, Howe JR.
    Ann Surg Oncol; 2017 Aug; 24(8):2206-2212. PubMed ID: 28560597
    [Abstract] [Full Text] [Related]

  • 15. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Mosquera C, Koutlas NJ, Fitzgerald TL.
    Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
    [Abstract] [Full Text] [Related]

  • 16. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
    Russo A, DiPeri T, Dumitra T, Tseng J, Pletcher E, Justo M, Chen C, Nissen N, Amersi F, Gong J, Hendifar A, Gangi A.
    J Neuroendocrinol; 2024 Aug; 36(8):e13399. PubMed ID: 38760997
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C, Wang W, Zhang Y, Feng X, Sun J, Zeng Y, Chen Y, Li Y, Chen M, Zhou Z, Chen J.
    Chin J Cancer; 2017 Jun 21; 36(1):51. PubMed ID: 28637502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroendocrine Gastroenteropancreatic Tumors: Where Are We?
    Ulla Rocha JL, Salgado A, Sardina Ferreiro R, Fernandez Catalina P, Gallardo E.
    Surg Laparosc Endosc Percutan Tech; 2017 Feb 21; 27(1):36-41. PubMed ID: 27977507
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.